How Indegene helps global pharma cos develop drugs faster amid Covid

Indegene uses AI and ML, and medical data mining to speed up digital transformation at top life sciences organisations

Humanigen, a biopharma company, needed to quickly increase the number of participants in its phase-3 clinical trial process for its drug Lenzilumab. This formulation is used by newly-hospitalised Covid-19 patients. It struggled to identify relevant trial participants from the high volume of generic website traffic and build credibility with patients and caregivers to participate in the trial. However, Indegene, a Bengaluru-based technology-led healthcare solutions provider, augmented Humanigen’s traditional CRO (contract research organisation) model with digital strategies, artificial intelligence and machine learning applications, and medical data mining for precise and effective targeting. The firm deployed engaging, data-driven digital campaigns for diverse